My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 312

    1.

    Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification.

    Colhoun HM, Scheek LM, Rubens MB, Van Gent T, Underwood SR, Fuller JH, Van Tol A.

    Diabetes. 2001 Mar;50(3):652-9.PMID: 11246887 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides.

    de Vries R, Perton FG, Dallinga-Thie GM, van Roon AM, Wolffenbuttel BH, van Tol A, Dullaart RP.

    Diabetes. 2005 Dec;54(12):3554-9.PMID: 16306375 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations.

    Dullaart RP, De Vries R, Scheek L, Borggreve SE, Van Gent T, Dallinga-Thie GM, Ito M, Nagano M, Sluiter WJ, Hattori H, Van Tol A.

    Scand J Clin Lab Invest. 2004;64(3):205-15.PMID: 15222630 [PubMed - indexed for MEDLINE]Related articles

    4.

    Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.

    Riemens S, van Tol A, Sluiter W, Dullaart R.

    Atherosclerosis. 1998 Sep;140(1):71-9.PMID: 9733217 [PubMed - indexed for MEDLINE]Related articles

    5.

    Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.

    Riemens SC, van Tol A, Sluiter WJ, Dullaart RP.

    Diabetologia. 1998 Aug;41(8):929-34.PMID: 9726595 [PubMed - indexed for MEDLINE]Related articles

    6.

    Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients.

    Riemens SC, van Tol A, Sluiter WJ, Dullaart RP.

    Diabetes. 1999 Aug;48(8):1631-7.PMID: 10426383 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Variations in serum cholesteryl ester transfer and phospholipid transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids.

    Lagrost L, Mensink RP, Guyard-Dangremont V, Temme EH, Desrumaux C, Athias A, Hornstra G, Gambert P.

    Atherosclerosis. 1999 Feb;142(2):395-402.PMID: 10030391 [PubMed - indexed for MEDLINE]Related articles

    8.

    Net mass transfer of plasma cholesteryl esters and lipid transfer proteins in normolipidemic patients with peripheral vascular disease.

    Rühling K, Lang A, Richard F, Van Tol A, Eisele B, Herzberg V, Till U.

    Metabolism. 1999 Nov;48(11):1361-6.PMID: 10582542 [PubMed - indexed for MEDLINE]Related articles

    9.

    Decreased plasma cholesterol esterification and cholesteryl ester transfer in hypopituitary patients on glucocorticoid replacement therapy.

    Beentjes JA, van Tol A, Sluiter WJ, Dullaart RP.

    Scand J Clin Lab Invest. 2000 May;60(3):189-98.PMID: 10885490 [PubMed - indexed for MEDLINE]Related articles

    10.

    Plasma cholesteryl ester transfer protein mass and phospholipid transfer protein activity are associated with leptin in type 2 diabetes mellitus.

    Dullaart RP, de Vries R, Dallinga-Thie GM, van Tol A, Sluiter WJ.

    Biochim Biophys Acta. 2007 Jan;1771(1):113-8. Epub 2006 Nov 15. Erratum in: Biochim Biophys Acta. 2007 Apr;1771(4):564. PMID: 17185032 [PubMed - indexed for MEDLINE]Related articles

    11.

    Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men.

    Dullaart RP, Hoogenberg K, Dikkeschei BD, van Tol A.

    Arterioscler Thromb. 1994 Oct;14(10):1581-5.PMID: 7918308 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification.

    Colhoun HM, Schalkwijk C, Rubens MB, Stehouwer CD.

    Diabetes Care. 2002 Oct;25(10):1813-7.PMID: 12351483 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men.

    Riemens SC, Van Tol A, Stulp BK, Dullaart RP.

    J Lipid Res. 1999 Aug;40(8):1467-74.PMID: 10428983 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients.

    Lagrost L, Athias A, Herbeth B, Guyard-Dangremont V, Artur Y, Paille F, Gambert P, Lallemant C.

    J Biol Chem. 1996 Aug 9;271(32):19058-65.PMID: 8702577 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes.

    Colhoun HM, Taskinen MR, Otvos JD, Van Den Berg P, O'Connor J, Van Tol A.

    Diabetes. 2002 Nov;51(11):3300-5.PMID: 12401722 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters.

    Cheung MC, Wolfbauer G, Albers JJ.

    Biochim Biophys Acta. 1996 Sep 27;1303(2):103-10.PMID: 8856039 [PubMed - indexed for MEDLINE]Related articles

    17.

    Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus.

    Tan KC, Shiu SW, Wong Y.

    Eur J Clin Invest. 2003 Apr;33(4):301-6.PMID: 12662160 [PubMed - indexed for MEDLINE]Related articles

    18.

    Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA.

    Desrumaux C, Athias A, Bessède G, Vergès B, Farnier M, Perségol L, Gambert P, Lagrost L.

    Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):266-75.PMID: 9974406 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins.

    Beentjes JA, van Tol A, Sluiter WJ, Dullaart RP.

    Atherosclerosis. 2000 Dec;153(2):491-8.PMID: 11164439 [PubMed - indexed for MEDLINE]Related articles

    20.

    Postprandial variations in the cholesteryl ester transfer protein activity, phospholipid transfer protein activity and plasma cholesterol efflux capacity in normolipidemic men.

    Syeda F, Senault C, Delplanque B, Le Roy B, Thaminy A, Gripois D, Blouquit MF, Ruelland A, Mendy F, Lutton C.

    Nutr Metab Cardiovasc Dis. 2003 Feb;13(1):28-36.PMID: 12772435 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity